GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (XCNQ:BETR) » Definitions » 3-Year EPS without NRI Growth Rate

BetterLife Pharma (XCNQ:BETR) 3-Year EPS without NRI Growth Rate : 46.00% (As of Oct. 2023)


View and export this data going back to 2017. Start your Free Trial

What is BetterLife Pharma 3-Year EPS without NRI Growth Rate?

BetterLife Pharma's EPS without NRI for the three months ended in Oct. 2023 was C$-0.00.

During the past 3 years, the average EPS without NRI Growth Rate was 46.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 21.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was -7.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of BetterLife Pharma was 46.50% per year. The lowest was -349.50% per year. And the median was 21.30% per year.


Competitive Comparison of BetterLife Pharma's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, BetterLife Pharma's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BetterLife Pharma's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's 3-Year EPS without NRI Growth Rate falls into.



BetterLife Pharma 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


BetterLife Pharma  (XCNQ:BETR) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


BetterLife Pharma 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


BetterLife Pharma (XCNQ:BETR) Business Description

Industry
Traded in Other Exchanges
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.
Executives
Ahmad Doroudian Director, Senior Officer